About Us
THE POWER OF A PROMISE. SMART. STRONG. SECURE.
| Contract Manufacturing and Active Pharmaceutical Ingredients
For more than 120 years, Abbott has been in the business of developing and producing pharmaceutical products. Since the 1960s, Abbott has expanded its focus to provide our customers with high-quality, innovative, cost-effective Biologics and Finished Goods Contract Manufacturing services and Active Pharmaceutical Ingredients to benefit the companies that put their trust in us. Put the Power of a Promise to work for you. Our Promise entails providing our customers with smart solutions, strong relationships and secure commitments that you deserve to help reach your projects full potential. |
 |
Contract Manufacturing
Finished Goods
 |
Abbott Contract Manufacturing services include a full range of Finished Goods Manufacturing Capabilities to address our clients' needs from beginning to end, with services to support material procurement, process optimization, formulation, testing and stability. We offer worldwide manufacturing locations to provide the flexibility you need to meet your regional and global requirements for Finished Goods manufacturing. |
Biologics
 |
Abbott offers you state-of-the-art Biologics Manufacturing Capabilities, including smart solutions to process design, analytical characterization and cGMP manufacturing, supporting the development and commercialization of your biopharmaceutical product. As an innovator, Abbott understands the importance of a strong and secure relationship with our partners. Abbott Bioresearch Center in Worcester, Massachusetts, is Abbott's multi-use cGMP biological Active Pharmaceutical Ingredient (API) manufacturing facility. The center has successfully completed more than 20 development programs for Abbott and third-party products. The Bioresearch Center is proud of all the successful collaborative development and manufacturing partnerships we have established in biologics since 1995. |
Fermentation
 |
Abbott is a leading U.S. pharmaceutical supplier of fermentation products, including erythromycin and specialty chemical products. Our wide range of fermentation manufacturing capabilities has allowed Abbott to be a Secure manufacturer of fermented products for more than 50 years, benefiting our customers' needs. Our state-of-the-art manufacturing facilities, combined with our depth of expertise, help us deliver on a promise for the highest quality products time and time again. |
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
 |
Abbott offers a wide range of compendia-grade Active Pharmaceutical Ingredients (API) and a variety of packaging sizes to meet our customers' needs. We give you the Power of a promise, knowing that Abbott is a secure supplier of quality APIs worldwide. |
Partner With Us Choose to Share the Power of a Promise. Contact us. |
 |
US Contacts: + 1-800-240-1043
Abbott
1401 Sheridan Road
North Chicago, IL 60064
UNITED STATES
Phone: 1-847-938-8524
Fax: 847-937-6676
- High Potency
- Finished Goods Contract Manufacturing
- Drug Delivery
- Proteins
- Monoclonal Antibodies
- Contract Packaging
- Pharmaceutical Contract Manufacturing
- Active Pharmaceutical Ingredients
- Fermentation
- Biologics Manufacturing
- Abbott Enhances Pharmaceutical Pipeline With Acquisition Of Facet Biotech
- Abbott Receives U.S. FDA Approval For Heat-Stable Norvir® (Ritonavir) Tablets
- Abbott Submits New Automated Ovarian Cancer Test For U.S. Approval
- Abbott And Pierre Fabre SA Announce Collaboration To Research And Develop Novel Treatments For Cancer
- Abbott Submits New HIV Test To FDA For Expedited Review
- Abbott's Ibis Technology Named One Of The Top Innovations For 2009 By The Scientist
- Abbott Announces Positive Three-Year Data On Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial
- Abbott Statement On ARBITER 6 - HALTS Results And Abbott's Niaspan (Niacin Extended-Release)
- Abbott To Acquire Novel Investigational Biologic To Treat Chronic Pain
- Abbott To Acquire Solvay Pharmaceuticals Business
- Abbott Receives FDA Approval For First Fully Automated Blood Screening Test For HIV-1/HIV-2
- Abbott Expands Use Of Sustainable Packaging As Part Of Global Environmental Efforts
- Abbott Announces Approval In China For Next-Generation XIENCE V® Drug Eluting Stent
- Abbott And GSK To Collaborate On Molecular Diagnostic Test To Select Candidate Patients For Future Cancer Immunotherapy